Extracellular Vesicles (EVs) from Levilactobacillus brevis YD9-MRS-1 Attenuate α-MSH-Induced Melanogenesis in B16F10 Cells via the MITF–Tyrosinase Axis and CREB, ERK, and AKT Signaling
Applied Sciences · 20.11.2026 · 16 (22) · 11500
DOI: 10.3390/app162211500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 20.11.2026. Verfasst von Jeong-Ha Lee und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of SMEs and Startups.
Abstract (Originalsprache)
Background
Hyperpigmentation results from dysregulated melanogenesis, while existing tyrosinase inhibitors are limited by safety and stability concerns. Extracellular vesicles (EVs) from lactic acid bacteria are well-defined, cell-free nanoparticles, but their effects on melanogenesis remain poorly understood. We investigated whether EVs derived from Levilactobacillus brevis YD9-MRS-1 (YD9-EVs) attenuate α-MSH-induced melanogenic signaling upstream of microphthalmia-associated transcription factor (MITF) and associated cellular signaling.
Methods
After characterization by nanoparticle tracking analysis, YD9-EVs were investigated in α-MSH-induced B16F10 cells to determine their effects on melanin synthesis, cellular tyrosinase activity, the expression of melanogenic regulators and enzymes (MITF, TYR, TRP-1, and TRP-2), and CREB-, PKA-, ERK-, and AKT-mediated signaling. Formulation tolerability was further evaluated using a human skin patch test.
Results
YD9-EVs formed a homogeneous nanoparticle population, associated with B16F10 cells, and were non-cytotoxic within the tested range. In α-MSH-stimulated cells, YD9-EVs dose-dependently reduced melanin content and tyrosinase activity, with numerically greater effects than arbutin at the highest concentration. These effects were accompanied by decreased expression of MITF, TYR, TRP-1, and TRP-2, reduced CREB and ERK phosphorylation, increased AKT phosphorylation, and no consistent change in PKA phosphorylation. The formulation containing the highest active YD9-EV concentration caused no irritation in the human skin patch test.
Conclusions
The anti-melanogenic activity of YD9-EVs was associated with downregulation of MITF, TYR, TRP-1, and TRP-2 and concurrent changes in CREB, ERK, and AKT signaling pathways. Although consistent suppression of PKA phosphorylation was not observed, the overall findings, together with the demonstrated short-term skin tolerability, support the further development of YD9-EVs as a cell-free candidate for hyperpigmentation control.
Förderung
- Ministry of SMEs and Startups
Zitieren
APA
Lee, J., Jayasingha, J. A. C. C., Ko, M., Hyeon, J. W., Kim, J., Bae, J., & Hyun, C. (2026). Extracellular Vesicles (EVs) from Levilactobacillus brevis YD9-MRS-1 Attenuate α-MSH-Induced Melanogenesis in B16F10 Cells via the MITF–Tyrosinase Axis and CREB, ERK, and AKT Signaling. Applied Sciences, 16(22), 11500. https://doi.org/10.3390/app162211500
Vancouver
Lee J, Jayasingha JACC, Ko M, Hyeon JW, Kim J, Bae J, et al. Extracellular Vesicles (EVs) from Levilactobacillus brevis YD9-MRS-1 Attenuate α-MSH-Induced Melanogenesis in B16F10 Cells via the MITF–Tyrosinase Axis and CREB, ERK, and AKT Signaling. Applied Sciences. 2026;16(22):11500. doi:10.3390/app162211500
BibTeX
@article{Lee2026,
author = {Lee, Jeong-Ha and Jayasingha, Jayasingha Arachchige Chathuranga Chanaka and Ko, Min-Nyeong and Hyeon, Jong Woo and Kim, Ji-Hyun and Bae, Jun-Tae and Hyun, Chang-Gu},
title = {Extracellular Vesicles (EVs) from Levilactobacillus brevis YD9-MRS-1 Attenuate α-MSH-Induced Melanogenesis in B16F10 Cells via the MITF–Tyrosinase Axis and CREB, ERK, and AKT Signaling},
journal = {Applied Sciences},
year = {2026},
volume = {16},
number = {22},
pages = {11500},
doi = {10.3390/app162211500}
}
EUVIMED